{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:33:43Z","timestamp":1788878023693,"version":"build-2803163510"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004785","name":"NordForsk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008368","name":"Danish Rheumatism Association","doi-asserted-by":"publisher","award":["R151-A4623"],"award-info":[{"award-number":["R151-A4623"]}],"id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008368","name":"Danish Rheumatism Association","doi-asserted-by":"publisher","award":["R161-A5262"],"award-info":[{"award-number":["R161-A5262"]}],"id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"the Swedish Rheumatism Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the King Gustaf V:s 80\u2009years Foundation"},{"DOI":"10.13039\/501100001862","name":"the Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Region Stockholm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore the association of maternal RA to pregnancy outcomes, especially preterm birth (PTB) and small for gestational age (SGA), in relation to disease activity and anti-rheumatic treatment before and during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>By linking prospective clinical rheumatology registers (CRR) in Sweden (the Swedish Rheumatology Quality Register, SRQ) and Denmark (the Danish clinical quality register, DANBIO) with medical birth registers, we identified 1739 RA-pregnancies and 17\u2009390 control-pregnancies (matched 1:10 on maternal age, birth year, parity) with delivery 2006\u201318. Disease activity (DAS28, CRP, HAQ score) and anti-rheumatic treatment 9\u2009months before and during pregnancy were identified through CRR and prescribed drug registers. Using logistic regression, we estimated adjusted odds ratios (aOR) with 95% CI for PTB and SGA overall and stratified by disease activity and anti-rheumatic treatment before and during pregnancy, adjusting for maternal characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found increased aOR of PTB [1.92 (1.56\u20132.35)] and SGA [1.93 (1.45\u20132.57)] in RA-pregnancies vs control-pregnancies. For RA-pregnancies with DAS28-CRP \u22654.1 vs &amp;lt;3.2 during pregnancy, aOR was 3.38 (1.52\u20137.55) for PTB and 3.90 (1.46\u201310.4) for SGA. Use of oral CS (yes\/no) during pregnancy resulted in an aOR of 2.11 (0.94\u20134.74) for PTB. The corresponding figure for biologics was 1.38 (0.66\u20132.89). Combination therapy, including biologics before pregnancy, was a marker of increased risk of both PTB and SGA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>During pregnancy, disease activity rather than treatment seems to be the most important risk factor for PTB and SGA in RA. Women with RA should be carefully monitored during pregnancy, especially if they have moderate to high disease activity or\/and are treated with extensive anti-rheumatic treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab894","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T07:17:25Z","timestamp":1638170245000},"page":"3711-3722","source":"Crossref","is-referenced-by-count":43,"title":["Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7149-0973","authenticated-orcid":false,"given":"Karin","family":"Hellgren","sequence":"first","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Insititutet"},{"name":"Department of Medicine Solna, Rheumatology, Theme Inflammation & Infection, Karolinska University Hospital , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Emilie","family":"Secher","sequence":"additional","affiliation":[{"name":"Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-8482","authenticated-orcid":false,"given":"Bente","family":"Glintborg","sequence":"additional","affiliation":[{"name":"Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2474-2677","authenticated-orcid":false,"given":"Ane Lille\u00f8re","family":"Rom","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, The Juliane Marie Centre"},{"name":"Department of Obstetrics, The Research Unit for Women\u2019s and Children\u2019s Health, The Juliane Marie Centre, Copenhagen University Hospital Rigshospitalet , Copenhagen"},{"name":"Research Unit of Gynecology and Obstetrics, Department of Clinical Research, University of Southern Denmark , Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Gudbjornsson","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology Research (ICEBIO), University Hospital, Faculty of Medicine, University of Iceland, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Michelsen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Research, Diakonhjemmet Hospital, Oslo"},{"name":"Division of Rheumatology, Department of Medicine, Hospital of Southern Norway Trust , Kristiansand, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Granath","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Insititutet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4229-6818","authenticated-orcid":false,"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[{"name":"Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"2022090108133622500_keab894-B1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.2010.02239.x","article-title":"Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study","volume":"268","author":"N\u00f8rgaard","year":"2010","journal-title":"J Intern Med"},{"key":"2022090108133622500_keab894-B2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/aogs.12324","article-title":"Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry","volume":"93","author":"Wallenius","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2022090108133622500_keab894-B3","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/art.38874","article-title":"Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study","volume":"66","author":"Rom","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2022090108133622500_keab894-B4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semarthrit.2019.03.011","article-title":"Obstetric outcomes in women with rheumatoid arthritis: results from Nationwide Inpatient Sample Database 2003-2011","volume":"49","author":"Kishore","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2022090108133622500_keab894-B5","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study","volume":"60","author":"de Man","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022090108133622500_keab894-B6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3899\/jrheum.140583","article-title":"Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the Organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy Project","volume":"42","author":"Bharti","year":"2015","journal-title":"J Rheumatol"},{"key":"2022090108133622500_keab894-B7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/rheumatology\/key053","article-title":"Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters","volume":"57","author":"Zbinden","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2022090108133622500_keab894-B8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/acr.23621","article-title":"Patient-reported disease activity and adverse pregnancy outcomes in systemic lupus erythematosus and rheumatoid arthritis","volume":"71","author":"Harris","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022090108133622500_keab894-B9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/acr.23730","article-title":"Factors associated with preterm delivery among women with rheumatoid arthritis and women with juvenile idiopathic arthritis","volume":"71","author":"Smith","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022090108133622500_keab894-B10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022090108133622500_keab894-B11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2022090108133622500_keab894-B12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol (Hoboken)"},{"key":"2022090108133622500_keab894-B13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17512433.2018.1525293","article-title":"The use of biologics and small molecules in pregnant patients with rheumatic diseases","volume":"11","author":"Gerosa","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2022090108133622500_keab894-B14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40265-020-01346-4","article-title":"Safety of new biologics (vedolizumab and ustekinumab) and small molecules (tofacitinib) during pregnancy: a review","volume":"80","author":"Gisbert","year":"2020","journal-title":"Drugs"},{"key":"2022090108133622500_keab894-B15","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1212\/NXI.0000000000000453","article-title":"Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD","volume":"5","author":"Das","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2022090108133622500_keab894-B16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/kez405","article-title":"Oral corticosteroid use during pregnancy and risk of preterm birth","volume":"59","author":"Palmsten","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2022090108133622500_keab894-B17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/art.24003","article-title":"Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study","volume":"59","author":"de Man","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2022090108133622500_keab894-B18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41584-019-0351-2","article-title":"Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity","volume":"16","author":"Forger","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2022090108133622500_keab894-B19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/03009742.2014.927918","article-title":"How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?","volume":"44","author":"Wadstr\u00f6m","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"2022090108133622500_keab894-B20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/CLEP.S141438","article-title":"Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry","volume":"9","author":"Ibfelt","year":"2017","journal-title":"Clin Epidemiol"},{"key":"2022090108133622500_keab894-B21","volume-title":"The Swedish medical birth register-a summary of content and quality","author":"K\u00e4ll\u00e9n","year":"2003"},{"key":"2022090108133622500_keab894-B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","article-title":"The Danish Medical Birth Register","volume":"33","author":"Bliddal","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"2022090108133622500_keab894-B23","doi-asserted-by":"crossref","first-page":"e000655","DOI":"10.1136\/rmdopen-2018-000655","article-title":"Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example","volume":"4","author":"Chatzidionysiou","year":"2018","journal-title":"RMD Open"},{"key":"2022090108133622500_keab894-B24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/ard.2005.045872","article-title":"Swedish registers to examine drug safety and clinical issues in RA","volume":"65","author":"Askling","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2022090108133622500_keab894-B25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"2022090108133622500_keab894-B26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2022090108133622500_keab894-B27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022090108133622500_keab894-B28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"2022090108133622500_keab894-B29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2022090108133622500_keab894-B30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2022090108133622500_keab894-B31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/art.22773","article-title":"Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis","volume":"57","author":"de Man","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2022090108133622500_keab894-B32"},{"key":"2022090108133622500_keab894-B33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2022090108133622500_keab894-B34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/EDE.0000000000000818","article-title":"Absolute risks of obstetric outcomes by maternal age at first birth: a population-based cohort","volume":"29","author":"Schummers","year":"2018","journal-title":"Epidemiology"},{"key":"2022090108133622500_keab894-B35","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1080\/14622200410001669187","article-title":"The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes","volume":"6(Suppl 2","author":"Cnattingius","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"2022090108133622500_keab894-B36","doi-asserted-by":"crossref","first-page":"j1","DOI":"10.1136\/bmj.j1","article-title":"Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child","volume":"356","author":"Catalano","year":"2017","journal-title":"BMJ"},{"key":"2022090108133622500_keab894-B37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa031587","article-title":"Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth","volume":"350","author":"Surkan","year":"2004","journal-title":"N Eng J Med"},{"key":"2022090108133622500_keab894-B38","doi-asserted-by":"crossref","first-page":"e015402","DOI":"10.1136\/bmjopen-2016-015402","article-title":"Risk of recurrent spontaneous preterm birth: a systematic review and meta-analysis","volume":"7","author":"Phillips","year":"2017","journal-title":"BMJ Open"},{"key":"2022090108133622500_keab894-B39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13075-017-1346-5","article-title":"Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition","volume":"19","author":"Schoels","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2022090108133622500_keab894-B40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2307\/2531734","article-title":"Models for longitudinal data: a generalized estimating equation approach","volume":"44","author":"Zeger","year":"1988","journal-title":"Biometrics"},{"key":"2022090108133622500_keab894-B41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"2022090108133622500_keab894-B42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ppe.12087","article-title":"Predicting risk of spontaneous preterm delivery in women with a singleton pregnancy","volume":"28","author":"Morken","year":"2014","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2022090108133622500_keab894-B43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jamapediatrics.2018.5541","article-title":"Associations of maternal diabetes and body mass index with offspring birth weight and prematurity","volume":"173","author":"Kong","year":"2019","journal-title":"JAMA Pediatr"},{"key":"2022090108133622500_keab894-B44","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.30210","article-title":"Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth","volume":"63","author":"Wallenius","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2022090108133622500_keab894-B45","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/annrheumdis-2016-210879","article-title":"Juvenile onset arthritis and pregnancy outcome: a population-based cohort study","volume":"76","author":"Remaeus","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022090108133622500_keab894-B46","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/1471-0528.15836","article-title":"Maternal and infant pregnancy outcomes in women with psoriatic arthritis: a Swedish nationwide cohort study","volume":"126","author":"Remaeus","year":"2019","journal-title":"BJOG"},{"key":"2022090108133622500_keab894-B47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1471-0528.15970","article-title":"Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population-based cohort study","volume":"127","author":"Kolstad","year":"2020","journal-title":"BJOG"},{"key":"2022090108133622500_keab894-B48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10995-017-2358-0","article-title":"Making decisions about medication use during pregnancy: implications for communication strategies","volume":"22","author":"Lynch","year":"2018","journal-title":"Matern Child Health J"},{"key":"2022090108133622500_keab894-B49","first-page":"9","article-title":"High rate of preterm birth in pregnancies complicated by rheumatoid arthritis","volume":"31","author":"Langen","year":"2014","journal-title":"Am J Perinatol"},{"key":"2022090108133622500_keab894-B50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/annrheumdis-2020-218356","article-title":"EULAR recommendations for a core data set for pregnancy registries in rheumatology","volume":"80","author":"Meissner","year":"2021","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab894\/41860317\/keab894.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/9\/3711\/45626599\/keab894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/9\/3711\/45626599\/keab894.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T04:29:53Z","timestamp":1662006593000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/9\/3711\/6448782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,12,3]]},"published-print":{"date-parts":[[2022,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab894","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2021,12,3]]}}}